BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2787049)

  • 21. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.
    Minisola S; Scarnecchia L; Scarda A; Bigi F; Tabolli S; Valtorta C; Mazzuoli G
    Miner Electrolyte Metab; 1988; 14(4):201-7. PubMed ID: 3264876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD; Wahner HW; Mann KG; Riggs BL
    J Lab Clin Med; 1983 Oct; 102(4):470-6. PubMed ID: 6604769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
    Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
    J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-associated Hypercalcemia in a patient with Paget's disease.
    Hung HC; Ou HY; Huang JS; Chuang MC; Wu TJ
    Kaohsiung J Med Sci; 2008 Mar; 24(3):152-6. PubMed ID: 18364276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.
    Rapado A; de la Piedra C; Torres R
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():30-4. PubMed ID: 2788062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone turnover in spinal osteoporosis.
    Pødenphant J; Johansen JS; Thomsen K; Riis BJ; Leth A; Christiansen C
    J Bone Miner Res; 1987 Dec; 2(6):497-503. PubMed ID: 3502682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
    Wilczek H; Stĕpán J; Justová V
    Cas Lek Cesk; 1995 Dec; 134(24):785-7. PubMed ID: 8599821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The correlation between the serum levels of osteocalcin and 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Castro Errecarborde N; de la Piedra Gordo C; Rapado Errazti A
    An Med Interna; 1990 Jun; 7(6):286-90. PubMed ID: 2102732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association between Paget's disease and primary hyperparathyroidism].
    Sarli MA; Spivacow R; Morillo S; Zanchetta JR
    Medicina (B Aires); 1997; 57(6):685-92. PubMed ID: 9674189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in phospho-calcium metabolic factors in function of the rate of bone turnover. Epidemiologic study of osteoporosis (part 2)].
    Maini M; Brignoli E; Felicetti G; Bozzi M
    Minerva Med; 1996 Dec; 87(12):565-76. PubMed ID: 9064593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ; Wolfert RL; Hill CS
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone turnover markers in tumor pathology with bone involvement].
    Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
    Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexisting Paget's disease of bone and hyperparathyroidism.
    Ooi TC; Evans MC; Spiro TP; Ibbertson HK
    N Z Med J; 1980 Feb; 91(654):134-6. PubMed ID: 6929972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of biochemical markers of bone turnover in rats after clodronate administration.
    Díaz Diego EM; de la Piedra C
    Miner Electrolyte Metab; 1993; 19(6):368-72. PubMed ID: 8164618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ; Presl J; Broulík P; Pacovský V
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum bone GLA-protein in growth hormone deficient children.
    Delmas PD; Chatelain P; Malaval L; Bonne G
    J Bone Miner Res; 1986 Aug; 1(4):333-8. PubMed ID: 3509741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment.
    Coulton LA; Preston CJ; Couch M; Kanis JA
    Arthritis Rheum; 1988 Sep; 31(9):1142-7. PubMed ID: 3048274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Different behavior of bone turnover markers in endocrine (extrinsic) and structural (intrinsic) osteopathies].
    Napal J; Amado JA; Riancho JA; Freijanes J; Pesquera C; González-Macías J
    Med Clin (Barc); 1990 Mar; 94(8):294-8. PubMed ID: 2342391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.